"Uveal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the UVEA.
| Descriptor ID |
D014604
|
| MeSH Number(s) |
C04.588.364.978 C11.319.494 C11.941.855
|
| Concept/Terms |
Uveal Neoplasms- Uveal Neoplasms
- Neoplasm, Uveal
- Neoplasms, Uveal
- Uveal Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Uveal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Uveal Neoplasms".
This graph shows the total number of publications written about "Uveal Neoplasms" by people in this website by year, and whether "Uveal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 1 | 3 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 2 | 0 | 2 |
| 2020 | 2 | 1 | 3 |
| 2021 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 2 | 0 | 2 |
| 2025 | 2 | 0 | 2 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Uveal Neoplasms" by people in Profiles.
-
Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report. Front Immunol. 2026; 17:1864115.
-
Five-year survival with tebentafusp in metastatic uveal melanoma. Ann Oncol. 2026 Sep; 37(9):1266-1277.
-
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients. Clin Cancer Res. 2025 Dec 01; 31(23):5027-5036.
-
Staged I-125 Eye Plaque Brachytherapy for the Treatment of Large Uveal Melanoma: A Single Institution Experience. Pract Radiat Oncol. 2026 Jan-Feb; 16(1):40-47.
-
Re-treatment of locally recurrent uveal melanoma with repeat eye plaque I-125 brachytherapy: A single institution experience. Brachytherapy. 2024 Sep-Oct; 23(5):604-609.
-
GZ17-6.02 kills PDX isolates of uveal melanoma. Oncotarget. 2024 05 17; 15:328-344.
-
Retrospective Analysis of Radiation-Induced Complications of Uveal Melanoma Patients Treated With Brachytherapy in the Era of Anti-VEGF. Am J Ophthalmol. 2024 04; 260:49-59.
-
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma. N Engl J Med. 2023 12 14; 389(24):2256-2266.
-
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. N Engl J Med. 2021 09 23; 385(13):1196-1206.
-
Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study. J Immunother Cancer. 2020 06; 8(1).